HighTower Advisors LLC Raises Position in Option Care Health, Inc. (NASDAQ:OPCH)

HighTower Advisors LLC grew its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 10.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 401,061 shares of the company's stock after buying an additional 36,308 shares during the period. HighTower Advisors LLC owned approximately 0.24% of Option Care Health worth $12,514,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. FMR LLC increased its position in shares of Option Care Health by 134.0% in the third quarter. FMR LLC now owns 7,516,448 shares of the company's stock worth $235,265,000 after purchasing an additional 4,304,896 shares during the period. Westfield Capital Management Co. LP boosted its stake in Option Care Health by 10.2% in the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company's stock valued at $203,204,000 after buying an additional 599,589 shares in the last quarter. Thrivent Financial for Lutherans boosted its stake in Option Care Health by 7.4% in the third quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company's stock valued at $183,541,000 after buying an additional 404,811 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in Option Care Health by 6.5% in the second quarter. Dimensional Fund Advisors LP now owns 3,605,271 shares of the company's stock valued at $99,870,000 after buying an additional 218,844 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA boosted its stake in Option Care Health by 2.6% in the third quarter. Massachusetts Financial Services Co. MA now owns 2,518,923 shares of the company's stock valued at $78,842,000 after buying an additional 63,955 shares in the last quarter. Institutional investors own 98.05% of the company's stock.

Option Care Health Trading Up 0.6 %

OPCH stock traded up $0.13 during mid-day trading on Friday, reaching $22.85. The company's stock had a trading volume of 1,166,475 shares, compared to its average volume of 2,120,894. The company has a market cap of $3.89 billion, a price-to-earnings ratio of 19.20, a price-to-earnings-growth ratio of 2.45 and a beta of 1.33. The business's 50 day moving average price is $26.04 and its 200 day moving average price is $28.66. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $34.63.

Insider Activity

In related news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the business's stock in a transaction that occurred on Friday, November 8th. The shares were bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.64% of the company's stock.

Analyst Ratings Changes

A number of analysts have recently commented on OPCH shares. UBS Group started coverage on Option Care Health in a research note on Thursday. They set a "neutral" rating and a $26.00 price target on the stock. Barrington Research cut their price target on Option Care Health from $40.00 to $32.00 and set an "outperform" rating on the stock in a research note on Thursday, October 31st. Truist Financial cut their price target on Option Care Health from $41.00 to $34.00 and set a "buy" rating on the stock in a research note on Friday, November 1st. The Goldman Sachs Group lowered Option Care Health from a "buy" rating to a "neutral" rating and cut their price target for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Finally, JMP Securities lifted their price target on Option Care Health from $36.00 to $37.00 and gave the company a "market outperform" rating in a research note on Monday, September 30th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $30.14.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.